CARL H. ROSNER
Carl H. Rosner, Chairman and CEO of CardioMag Imaging Inc., founded that Company in 1999. He is also the principal founder of Intermagnetics General Corporation (IGC), a company that had a market capitalization in excess of One Billion Dollars. In November 2006 Intermagnetics was acquired by Royal Philips Electronics for $1.3 Billion. IGC’s principal activities were focused on the design, development and manufacture of wire and magnets to the physics research community and sale of superconductive MRI components used in the medical diagnostic imaging marketplace.
Prior to founding IGC in 1971, he was Manager of GE's Superconductive (S.C.) Products Operation. Earlier, as Staff Scientist for 12 years at GE's R&D Center, he was engaged in the characterization of metallic and non-metallic materials, the development of scientific instrumentation, as well as supervision of GE's electrical and magnetic measurement laboratory. In 1961, he became a member of the GE research team exploring applied high-field SC materials and magnet research problems. Subsequently, Mr. Rosner was responsible for the transition of the materials and device-oriented SC technology from the R&D stage towards commercialization within GE, as a precursor to the establishment of IGC to commercialize the energy saving and then emerging medical device (MRI) technology. Before joining GE in 1955, he held research associate positions at Upsala University and the Royal Institute of Technology in Stockholm, Sweden. Mr. Rosner is a graduate of the Stockholm Institute of Technology, Newark College of Engineering and Rensselaer Polytechnic Institute with undergraduate and graduate degrees in electrical engineering and business management. He is the author and co-author of many published papers on superconductive and electronic devices. He holds seven patents and is a well-known authority in his field.
Following the spin-off from GE, Intermagnetics - under his leadership - became the foremost independent U.S. producer of high field superconducting (SC) materials, magnet systems and cryogenic refrigeration equipment. The company - now under Philips ownership - serves major industrial, medical and research markets throughout the United States, Europe and Asia, but is no longer listed on the NASDAQ Stock Exchange (IMGC). From 1980 through 1983, while remaining Chairman of the IGC Board, Mr. Rosner was President of TDC Technology Development Corporation, Canada, a venture capital and technology
management/consulting company whose portfolio included investments valued at over $30 million. During this period, TDC was also a major IGC shareholder. In 1984, Mr. Rosner was re-elected President and Chief Executive Officer of IGC, a position he held until 1999. He retired from that office in 1999 while continuing as a Director and Chairman of the Board of Intermagnetics until Fiscal 2002 when he retired to devote himself fulltime to CardioMag Imaging, Inc.
He is an eloquent and effective contributor to the scientific and industrial growth of the superconductive and medical MRI equipment industry. As such he was elected a member of The National Academy of Engineering in 1996 and in 2002 was the recipient of The IEEE Max Swerdlow Award for Sustained Service to the Applied Superconductivity Community. He received the Entrepreneur of the Year Award in 1992 for Manufacturing. Appointed by Governor Cuomo, Mr. Rosner served as an At-Large Member of the Executive Board of the New York State Institute on Superconductivity and is a past board member and program chairman of the International Industrial Symposium on the Supercollider (IISSC). He served as a member of the Board of Directors of the Council on Superconductivity for American Competitiveness (CSAC), of which he was Chairman of the MagLev 2000 Task Force. Mr. Rosner also served on the editorial board of both the JOURNAL OF SUPERCONDUCTIVITY and SUPERCONDUCTOR INDUSTRY and was a member of a U.S. - U.S.S.R. technology exchange program. Other affiliations include Senior membership in the Institute of Electrical and Electronics Engineers (IEEE), formerly chairing the IEEE Technical Committee on Cryo-electrical Engineering. He is also a member of the American Physical Society, the American Association for the Advancement of Science, and the New York Academy of Science. He was presented with the 2002 Excellence in Entrepreneurship Award from the University at Albany and served on the board of directors of Ultralife Batteries, Inc. He was a Director of the University at Albany Foundation. In addition, Mr. Rosner was appointed by Governor George Pataki as a Director to the Arsenal Business and Technology Partnership in Watervliet, NY. He was also honored for a lifetime of business success and service to the New York State Capital Region by being inducted into the 2004 Business Hall of Fame. In June of 2010, he was awarded the Center for Economic Growth’s Technology Entrepreneur Award. Most recently, he was honored by the IEEE’s Council of Superconductivity, who minted a unique coin that will be presented annually in his name to winners of an annual entrepreneurial business start-up competition.
ABOUT CardioMag Imaging, Inc.
CardioMag Imaging, Inc. (CMI) is a privately held medical device company founded in 1999 and is engaged in the development and commercialization of a unique kind of cardiac diagnostic device known as MagnetoCardioGraphs (MCG). The device the company has developed consists of the integration of highly sophisticated proprietary sensors, electronics, and software.
The company’s MCG system is a non-invasive cardiac medical diagnostic device that provides unique and clinically relevant information about heart function without use of ionizing radiation. CardioMag’s MCG system is the world's first and only MCG system to obtain FDA approval. The basis of the device relies on analyzing magnetic fields generated by the heart’s electrical activity. As such, it can be applied broadly, from prevention through diagnosis, to determine the relative risk of cardiac rehabilitation. From the MCG analysis of ventricular repolarization alone, the physician can tell whether a patient has underlying coronary artery disease and-using beat-to-beat analysis-the relative risk of sudden cardiac death.
Recent clinical research suggests that MCG has the diagnostic power of nuclear imaging techniques such as Single Photon Emission Computed Tomography (SPECT), but without the use of ionizing radiation and without submitting the patient to physical or pharmacologically induced stress.
CMI has been granted numerous patents (pending if indicated) pertaining to this groundbreaking technology: